Literature DB >> 23436074

The emerging role of FDG PET/CT in rectal cancer management: is it time to use the technique for early prognostication?

Luca Tagliabue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23436074     DOI： 10.1007/s00259-013-2367-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  28 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

Review 2.  Complete clinical response after preoperative chemoradiation in rectal cancer: is a "wait and see" policy justified?

Authors:  R Glynne-Jones; M Wallace; J I L Livingstone; J Meyrick-Thomas
Journal:  Dis Colon Rectum       Date:  2007-11-28       Impact factor: 4.585

3.  Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.

Authors:  Claus Rödel; Peter Martus; Thomas Papadoupolos; Laszlo Füzesi; Martin Klimpfinger; Rainer Fietkau; Torsten Liersch; Werner Hohenberger; Rudolf Raab; Rolf Sauer; Christian Wittekind
Journal:  J Clin Oncol       Date:  2005-10-24       Impact factor: 44.544

4.  Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.

Authors:  Andrea Gallamini; Caterina Patti; Simonetta Viviani; Andrea Rossi; Francesca Fiore; Francesco Di Raimondo; Maria Cantonetti; Caterina Stelitano; Tatyana Feldman; Paolo Gavarotti; Roberto Sorasio; Antonino Mulè; Monica Leone; Alessandro Rambaldi; Alberto Biggi; Sally Barrington; Federico Fallanca; Umberto Ficola; Stéphane Chauvie; Alessandro Massimo Gianni
Journal:  Br J Haematol       Date:  2010-12-20       Impact factor: 6.998

Review 5.  The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.

Authors:  R Glynne-Jones; S Mawdsley; J R Novell
Journal:  Colorectal Dis       Date:  2006-11       Impact factor: 3.788

Review 6.  PET/CT imaging in different types of lung cancer: an overview.

Authors:  Valentina Ambrosini; Silvia Nicolini; Paola Caroli; Cristina Nanni; Arianna Massaro; Maria Cristina Marzola; Domenico Rubello; Stefano Fanti
Journal:  Eur J Radiol       Date:  2011-03-31       Impact factor: 3.528

Review 7.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Authors:  C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

8.  Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement?

Authors:  Bruce E Hillner; Anna N Tosteson; Yunjie Song; Tor D Tosteson; Tracy Onega; David C Goodman; Barry A Siegel
Journal:  J Am Coll Radiol       Date:  2012-01       Impact factor: 5.532

9.  Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.

Authors:  Laurence Collette; Jean-Francois Bosset; Marcel den Dulk; France Nguyen; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Marianne Piérart; Gilles Calais
Journal:  J Clin Oncol       Date:  2007-10-01       Impact factor: 44.544

10.  The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer.

Authors:  M J Murcia Duréndez; L Frutos Esteban; J Luján; M D Frutos; G Valero; J L Navarro Fernández; L Mohamed Salem; G Ruiz Merino; M A Claver Valderas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-19       Impact factor: 9.236
View more
  4 in total

Review 1.  Positron Emission Tomography (PET) in Oncology.

Authors:  Andrea Gallamini; Colette Zwarthoed; Anna Borra
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

2.  Metabolic and molecular relative percentage coreduction in patients with locally advanced rectal cancer treated with neoadjuvant therapy.

Authors:  Claudio V Sole; Felipe A Calvo; Emilio Alvarez; Jose L Carreras
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-17       Impact factor: 9.236

3.  The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the primary staging of rectal cancer.

Authors:  Salih Erpulat Ozis; Cigdem Soydal; Cihangir Akyol; Nalan Can; Ozlem Nuriye Kucuk; Cemil Yagcı; Ayhan Bulent Erkek; Mehmet Ayhan Kuzu
Journal:  World J Surg Oncol       Date:  2014-02-01       Impact factor: 2.754

4.  The Impact of Primary Tumor and Locoregional Metastatic Lymph Node SUVmax on Predicting Survival in Patients with Rectal Cancer.

Authors:  Göksel Alçın; Yasemin Şanlı; Gülçin Yeğen; Esra Kaytan Sağlam; Tevfik Fikret Çermik
Journal:  Mol Imaging Radionucl Ther       Date:  2020-04-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.